Real-world data on the occurrence of vaso-occlusive crises (VOCs) in patients with sickle cell disease (SCD) and a high baseline disease burden treated with crizanlizumab: results from a managed access program (MAP) (2021)
- Authors:
- Autor USP: PINTO, ANA CRISTINA SILVA - FMRP
- Unidade: FMRP
- DOI: 10.1182/blood-2021-152407
- Assunto: ANEMIA FALCIFORME
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2021
- Source:
- Conference titles: ASH Annual Meeting Abstracts
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
CANÇADO, Rodolfo D. et al. Real-world data on the occurrence of vaso-occlusive crises (VOCs) in patients with sickle cell disease (SCD) and a high baseline disease burden treated with crizanlizumab: results from a managed access program (MAP). Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2021-152407. Acesso em: 27 dez. 2025. , 2021 -
APA
Cançado, R. D., Colombatti, R., Quarta, A., Arcioni, F., DeBonnett, L., Soliman, W., et al. (2021). Real-world data on the occurrence of vaso-occlusive crises (VOCs) in patients with sickle cell disease (SCD) and a high baseline disease burden treated with crizanlizumab: results from a managed access program (MAP). Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2021-152407 -
NLM
Cançado RD, Colombatti R, Quarta A, Arcioni F, DeBonnett L, Soliman W, Sarkar R, Pinto ACS. Real-world data on the occurrence of vaso-occlusive crises (VOCs) in patients with sickle cell disease (SCD) and a high baseline disease burden treated with crizanlizumab: results from a managed access program (MAP) [Internet]. Blood. 2021 ; 138 4180-4182.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1182/blood-2021-152407 -
Vancouver
Cançado RD, Colombatti R, Quarta A, Arcioni F, DeBonnett L, Soliman W, Sarkar R, Pinto ACS. Real-world data on the occurrence of vaso-occlusive crises (VOCs) in patients with sickle cell disease (SCD) and a high baseline disease burden treated with crizanlizumab: results from a managed access program (MAP) [Internet]. Blood. 2021 ; 138 4180-4182.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1182/blood-2021-152407 - A hidroxicarbamida atua sobre componentes do metabolismo da adenosina em células sanguíneas de pacientes com anemia falciforme
- The neonatal screening program in Brazil, Focus on Sickle Cell Disease (SCD)
- Efeito do tratamento com hidroxiuréia sobre as células hematopoéticas da medula óssea de pacientes com anemia falciforme
- Burden of sickle cell disease: a Brazilian societal perspective analysis
- Novel Insights into the Pathophysiology and Treatment of Sickle Cell Disease
- Sickle cell disease mortality in Brazil: real-world evidence
- Infecção por SARS-CoV-2 na doença falciforme - relato da experiência em um centro de referência no Brasil
- Six-point DIXON and magnetic resonance spectroscopy techniques in quantifying bone marrow fat in sickle cell disease
- Qualitative and quantitative magnetic resonance imaging evaluation of bone tissue vaso-occlusive events in patients with sickle cell disease
- Definição dos haplótipos do gene da β-globina em pacientes com doença falciforme da região sudeste do Brasil utilizando um ensaio snapshot multiplex
Informações sobre o DOI: 10.1182/blood-2021-152407 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003232561.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
